WebKPRX Kiora Pharmaceuticals Inc. Annual Income Statement MarketWatch Kiora Pharmaceuticals Inc. Annual stock financials by MarketWatch. View the latest KPRX financial statements, income... WebKPRX Kiora Pharmaceuticals Inc. Analyst Estimates MarketWatch Kiora Pharmaceuticals Inc. analyst estimates, including KPRX earnings per share estimates and analyst recommendations. Kiora...
KPRX Kiora Pharmaceuticals Inc. Analyst Estimates & Rating – …
Web6 apr. 2024 · Short interest is the volume of Kiora Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 48,300 shares of KPRX short. 2.86% of Kiora Pharmaceuticals' shares are currently sold short. Learn More on Kiora Pharmaceuticals' current short interest. WebThe company was founded by Sébastien St. CEO Charles Bowman Employees 689 Headquarters Gatineau, Québec Founded 2013 HEXO Key Statistics Market cap 51.58M Price-Earnings ratio -0.24 Dividend yield — Average volume 1.11M High today $1.44 Low today $1.18 Open price $1.25 Volume 3.64M 52 Week high $8.38 52 Week low $0.9006 … jobs at methodist willowbrook
KPRX Kiora Pharmaceuticals Inc. Analyst Estimates & Rating – WSJ
Web11 apr. 2024 · KPRX Price Target 2024 Kiora Pharmaceuticals Analyst Ratings Free Trial NASDAQ:KPRX Kiora Pharmaceuticals - KPRX Price Target & Analyst Ratings $3.50 -0.12 (-3.31%) (As of 04/11/2024 10:46 AM ET) Compare Today's Range $3.49 $3.66 50-Day Range $3.28 $6.94 52-Week Range $2.32 $26.20 Volume 4,509 shs Average Volume … WebCPRX Complete Catalyst Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Web3 okt. 2024 · MARKET PULSE Shares of Kiora Pharmaceuticals Inc. (KPRX) soared about 57% in premarket trading on Tuesday after the company said it will begin a Phase 2 clinical trial for its experimental eye... jobs at merry hill centre